Skip to main content

Month: June 2024

Planet 13 Announces Results of Annual General Meeting

LAS VEGAS, June 11, 2024 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the following results for each item of business considered at Planet 13’s Annual General Meeting of Stockholders held on Tuesday, June 11, 2024. Election of Directors The following table sets out the percentage of shares of common stock voted in respect of the election of directors.Nominee % For % WithheldRobert Groesbeck 98.63% 1.37%Larry Scheffler 98.54% 1.46%Lee Fraser 97.31% 2.69%Adrienne O’Neal 98.99% 1.01%Kevin Martin 99.33% 0.67%Ratification of Auditors The following table sets out the percentage of shares of common stock voted in respect of the ratification of the appointment of Davidson & Company...

Continue reading

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

WINSTON-SALEM, N.C., June 11, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an underwritten public offering and a concurrent registered direct offering of 53,719,009 shares of its Class A ordinary shares at a price of $2.42 per share, before applicable underwriting discounts and commissions. In addition, the underwriters will have a 30-day option to purchase up to an additional 15% of the Class A ordinary shares sold in the underwritten public offering. All of the Class A ordinary shares in the underwritten public offering and concurrent registered direct offering are being sold by the Company. The public offering and the concurrent registered direct offering are...

Continue reading

Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)

Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2 calendar year 2025, and anticipated for ShORe in mid-calendar year 2025 MELBOURNE, Australia and PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that the Company is seeking to raise up to approximately A$227.3 million (US$150.0 million1) via an approximately A$10.0 million (US$6.6 million1) placement (“Placement”) and an approximately A$217.3 million (US$143.4 million1) Accelerated...

Continue reading

Fireweed Announces Results from Annual General Meeting

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF), is pleased to announce the results of voting at its annual general and special meeting of shareholders which was held on June 11, 2024, in Vancouver, BC (the “Meeting”). Full details of all the voting results for the 2024 Meeting are available on SEDAR+ at www.sedarplus.ca. A total of 78,544,062 common shares, representing 52.93% of the votes attached to all outstanding shares as at the record date for the Meeting, were represented at the Meeting. All of the matters submitted to the shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular dated May 3, 2024, were approved by the requisite majority of votes cast at the Meeting. The nominees for directors...

Continue reading

Questor Announces New Vice President of Operations and Engineering and Director of Sales and Marketing

CALGARY, Alberta, June 11, 2024 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor”, the “Company”), (TSX Venture Exchange: QST) is pleased to announce Mr. Quentin Kyliuk, has joined the company as Vice President of Operations and Engineering and Ms. Stephanie Setiawan has joined as our team as Director of Sales and Marketing.   “Quentin’s diverse background in engineering and manufacturing will be a valuable asset to Questor’s leadership team. His experience in our client’s world, at engineering companies and manufacturing, will provide insightful perspectives and help drive our growth” said Ms. Audrey Mascarenhas.  Mr. Kyliuk brings over 25 years of experience in executing strategic projects and enhancing program profitability. Before joining Questor, Mr. Kyliuk was a Program Manager at Startec Compression and Process. Prior...

Continue reading

Grupo Aeroportuario del Pacifico Informs the Acquisition of 51.5% of the Shares Representing the Capital Stock of the Company “GWTC”

GUADALAJARA, Mexico, June 11, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC; BMV: GAP) (“the Company” or “GAP”) informs that today signed the acquisition of 51.5% of the shares representing the capital stock of the company Guadalajara World Trade Center, S.A. de C.V. (“GWTC”), for a total amount of Ps. 875,504,411.57 (EIGHT HUNDRED SEVENTY-FIVE MILLION FIVE HUNDRED FOUR THOUSAND FOUR HUNDRED ELEVEN PESOS 57/100). GWTC is a group consisting of seven companies that specialize in handling, storage, and custody services for international cargo. These services are provided in facilities classified as free trade zone (recinto fiscal) at Guadalajara Airport and Puebla Airport. In 2023, GWTC generated revenues above Ps. 1.0 billion, with an EBITDA margin of around 40%, and without financial debt. The...

Continue reading

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

PALO ALTO, Calif., June 11, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has entered into a commitment letter (the “Commitment Letter”) with Perigrove LLC and Graf Holdings (collectively the “Lender”) for a $100 million 5-year term financing with royalty-based payments (“Commitment”). The Company intends to use the funds to repay the outstanding amount of its existing senior secured loan provided by Oramed Pharmaceuticals Inc., which is approximately $85 million. The Company intends to use the rest of the funds raised, which is estimated to be $15 million, for general corporate purposes. In...

Continue reading

The Keg Royalties Income Fund announces June 2024 cash distribution

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced that its June 2024 distribution of $0.0946 per unit has been declared and is payable to unitholders of record as at June 21, 2024. The June 2024 distribution will be paid on June 28, 2024. The Fund is a limited purpose, open-ended trust established under the laws of the Province of Ontario that, through The Keg Rights Limited Partnership, a subsidiary of the Fund, owns certain trademarks and other related intellectual property used by Keg Restaurants Ltd. (“KRL”). In exchange for use of those trademarks, KRL pays the Fund a royalty of 4% of gross sales of Keg restaurants included in the royalty pool. With approximately 10,000 employees, over 100 restaurants and annual system sales exceeding $700...

Continue reading

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

14-month data show treatment with setrusumab resulted in a large, sustained 67% reduction in annualized fracture rate and persistent median annualized fracture rate of 0.00 (p=0.0014) Treatment resulted in continued, substantial improvements in bone mineral density (BMD) with a mean increase from baseline of 22% (p

Continue reading

Dundee Precious Metals Files Technical Report on the Čoka Rakita Gold Project

TORONTO, June 11, 2024 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that the Company has filed a technical report for its Čoka Rakita gold project in Serbia (the “Report”). The purpose of the report was to support the preliminary economic assessment for Čoka Rakita, as previously disclosed in the Company’s news release dated May 1, 2024. The Report has been prepared pursuant to the Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The Report and the May 1, 2024, news release are both available for review on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.dundeeprecious.com). About Dundee Precious Metals Dundee Precious Metals Inc. is a Canadian-based international gold mining company with operations and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.